Financials Brighten Optix Corporation

Equities

6747

TW0006747009

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 03:30:00 17/05/2024 am IST 5-day change 1st Jan Change
177 TWD -0.28% Intraday chart for Brighten Optix Corporation -1.67% -6.60%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Capitalization 1 720.6 1,669 1,018 1,060 960.2 -
Enterprise Value (EV) 1 720.6 1,669 1,018 1,060 960.2 960.2
P/E ratio - - - - - -
Yield 3.78% 2.78% 4.87% - 6.22% 6.95%
Capitalization / Revenue 5.82 x 11.7 x 6.07 x 6.23 x 4.63 x 4.1 x
EV / Revenue 5.82 x 11.7 x 6.07 x 6.23 x 4.63 x 4.1 x
EV / EBITDA - 22 x 15.6 x 17.9 x 11 x 10.1 x
EV / FCF - 5,60,92,243 x 2,21,94,618 x - - -
FCF Yield - 0% 0% - - -
Price to Book 4.31 x - 3.65 x - - -
Nbr of stocks (in thousands) 22,000 24,189 24,189 24,189 24,189 -
Reference price 2 32.76 68.98 42.08 43.84 39.70 39.70
Announcement Date 25/03/21 25/03/22 31/03/23 15/03/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 123.8 143 167.6 170.3 207.2 234.4
EBITDA 1 - 75.9 65.12 59.2 87.38 95.24
EBIT 1 34.42 49.83 55.88 47.4 68.86 77.78
Operating Margin 27.8% 34.84% 33.35% 27.83% 33.23% 33.19%
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS - - - - - -
Free Cash Flow - 29.75 45.86 - - -
FCF margin - 20.8% 27.36% - - -
FCF Conversion (EBITDA) - 39.2% 70.42% - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 1.239 1.918 2.048 - 2.468 2.757
Announcement Date 25/03/21 25/03/22 31/03/23 15/03/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3
Net sales 1 - 49.62 35.42 44.16 35.64 52.82 36.38 42.5 46.31 61.18
EBITDA - - - - - - - - - -
EBIT 1 - 20.16 6.678 14.5 6.216 19.85 6.417 8.624 8.216 -
Operating Margin - 40.63% 18.85% 32.83% 17.44% 37.57% 17.64% 20.29% 17.74% -
Earnings before Tax (EBT) - - - - - - - - - -
Net income 14.48 - - - - - - - - -
Net margin - - - - - - - - - -
EPS 0.5982 - - - - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 11/08/22 11/11/22 31/03/23 15/05/23 09/08/23 10/11/23 15/03/24 14/05/24 - -
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - 29.7 45.9 - - -
ROE (net income / shareholders' equity) - - 21.1% - 22.5% 23.4%
ROA (Net income/ Total Assets) - - 18.2% - - -
Assets - - - - - -
Book Value Per Share 7.610 - 11.50 - - -
Cash Flow per Share - - - - - -
Capex - 15.5 16.5 - - -
Capex / Sales - 10.82% 9.87% - - -
Announcement Date 25/03/21 25/03/22 31/03/23 15/03/24 - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
39.7 CNY
Average target price
51.43 CNY
Spread / Average Target
+29.55%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6747 Stock
  4. Financials Brighten Optix Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW